UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

26 Jun 2023

Change in UCB’s Executive Committee

Read More
20 Jun 2023

UCB showcases commitment to transforming outcomes for people living with epilepsy and rare epileptic syndromes at European Pediatric Neurology Society (EPNS) Annual Congress

Read More
7 Jun 2023

UCB Receives New European Commission Approvals for BIMZELX[®]▼(bimekizumab) for the Treatment of Psoriatic Arthritis and Axial Spondyloarthritis

Read More
31 May 2023

New Long-Term Data on Bimekizumab in Psoriatic Arthritis and Axial Spondyloarthritis Presented at EULAR 2023

Read More
30 May 2023

UCB Showcases Commitment to Advancing Care in Immune-Mediated Inflammatory Diseases with 23 Abstracts at EULAR 2023

Read More
26 May 2023

Transparency notification FMR LLC

Read More

Stay up-to-date on the latest news and information from UCB